Intuitive Surgical Inc.

ISRG ·Healthcare, Medical Devices, United States
Analysis Moat Score

Moat Score — Intuitive Surgical Inc.

Total Moat Score 21 / 30
Moat Factor Score Analysis
Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. 4 / 5 Decades of FDA clearances, clinical evidence, and a historically dominant patent portfolio around the da Vinci platform gave Intuitive a near-monopoly; core patents are now expiring, but the accumulated clinical data and regulatory track record remain hard to replicate quickly.
Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. 3 / 5 Intuitive's enormous installed base and manufacturing scale in single-use instruments give it per-unit cost advantages over newer entrants still building out production and service infrastructure.
Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. 4 / 5 Intuitive has maintained premium pricing on both systems and recurring instruments for years with minimal need to discount, reflecting weak near-term competitive alternatives, though new entrants like Medtronic's Hugo could erode this over time.
Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. 2 / 5 Value increases indirectly as more surgeons get trained and more hospitals adopt da Vinci, since a larger trained-surgeon base and richer procedure-specific data reinforce the platform's appeal to new hospitals and trainees, though this is a weaker, more indirect network effect than a true multi-sided platform.
Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. 5 / 5 Hospitals that invest millions in da Vinci systems are locked into Intuitive's proprietary consumable instruments, and surgeons credentialed on the platform are reluctant to retrain on a competing system, creating an unusually powerful combination of economic and behavioral lock-in.
Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. 3 / 5 The capital, training infrastructure, and regulatory investment required to build a competing general-purpose surgical robotics platform are enormous, though well-capitalized rivals like Medtronic and J&J are now entering as patents expire, gradually eroding this barrier.